This study suggests that SATB1-AS1 may serve as a novel diagnostic biomarker and therapeutic target for pulpitis, providing a potential strategy to preserve pulp vitality and improve clinical outcomes.
Ding et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: